°Ë»ö
ä¿ë
Á¤º¸
    Àü¿µ±¸ ¾à»ç, Áö¹æ ÃʵîÇлý ÃÊû û¿Í´ë °ßÇÐ
    ±â»çÀÔ·Â : 10.08.03 09:54:31
    2 °¡
    ÇÃÄ£Ãß°¡
    ¾î¸°ÀÌ Á¾ÇÕ¿©¾çÁ¦µµ ¼±¹°¡¦¹ÎÁÖÆòÅë ¼ÛÆÄ±¸ ȸÀå ÀçÁ÷




    Àü¿µ±¸ Àü ¼­¿ï½Ã¾à»çȸÀåÀÌ ÃÖ±Ù °­¿øµµ¿Í ÃæÃ»ºÏµµ ¸ð¹ü ÃʵîÇлý 180¿©¸íÀ» ¼­¿ï·Î ÃÊÃ»ÇØ ÇÔ²² ½Ã°£À» º¸³»¸ç À̵éÀ» °Ý·ÁÇß´Ù.

    À̵é ÃʵîÇлýµéÀº û¿Í´ë¿Í KBS¹æ¼Û±¹À» Æ÷ÇÔÇÑ ¼­¿ï °¢Áö¸¦ µÑ·¯º¸°í Àü ȸÀåÀº À̵鿡°Ô ¾î¸°ÀÌ Á¾ÇÕ¿µ¾çÁ¦¸¦ ¼±¹°Çϱ⵵ Çß´Ù.

    ÇÑÆí Àü Àü ȸÀåÀº ÇöÀç ´ëÅë·É ÀÚ¹® Çå¹ý ±â°üÀÎ ¹ÎÁÖÆòÈ­ÅëÀÏ ÀÚ¹®È¸ÀÇ ¼ÛÆÄ±¸ ȸÀåÀ» ¸Ã°í ÀÖ´Ù.
    X
    AD
    ²ÜÁ¶ÇÕ Ã£¾Æº¸±â! À̺¥Æ®Âü¿© ¡æ
    ¹Úµ¿ÁØ ±âÀÚ(pdj30@dailypharm.com)
    ±ÛÀÚÅ©±â ¼³Á¤
    °¡³ª´Ù¶ó¸¶¹Ù»ç
    °¡³ª´Ù¶ó¸¶¹Ù»ç
    °¡³ª´Ù¶ó¸¶¹Ù»ç
    • Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â
    • 2025³â »ó¹Ý±â ¼ö½Ãä¿ë(ÇмúÀÇÇнÇ, BDÆÀ ¾à»ç) ¹Ù·Î°¡±â
    • °æ·ÂÁ÷ MRä¿ë (¼öµµ±Ç) ¹Ù·Î°¡±â
    • [Çѵ¶] Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®, MA, Ãѹ« ÆÀÀå, Á¦Á¶°ü¸® ¾à»ç, ÀÌÈ­ÇнÃÇè(QC), ±â¼úÆÀ ±³Á¤´ã´ç, Àü¹®ÀǾàǰ ¸¶ÄÉÆÃ, ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ ¹Ù·Î°¡±â
    • °­¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â
    • ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â
    • RA, PMS, MSL ,PM, MR, MM µî °¢ ºÎ¹® ¸ðÁý ¹Ù·Î°¡±â
    • R&D¼¾ÅÍ ¿¬±¸¿ø ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â
    • Sr. RA Specialist & RA Specialist (2 Year Contract) ¹Ù·Î°¡±â
    • [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â
    • º»»ç Medical Affairs ä¿ë ¹Ù·Î°¡±â
    • º»»ç ½ÅÀÔ RA ¾à»ç ä¿ë ¹Ù·Î°¡±â
    • !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
      10.08.03 18:33:09
      0 ¼öÁ¤ »èÁ¦ 0 0
    • Àü¿µ±¸ Àü ¼­¿ï½Ã¾à»çȸÀåÀÌ ÃÖ±Ù °­¿øµµ¿Í ÃæÃ»ºÏµµ ¸ð¹ü ÃʵîÇлý 180¿©¸íÀ» ¼­¿ï·Î ÃÊÃ»ÇØ ÇÔ²² ½Ã°£À» º¸³»¸ç À̵éÀ» °Ý·ÁÇß´Ù°í ÇÑ´Ù.°æºñ°¡ ¸¸¹ÎÄ¡ ¾Ê¾ÒÀ» °Í °°Àºµ¥ ´ë´ÜÇÏ´Ù.
      10.08.03 11:32:17
      0 ¼öÁ¤ »èÁ¦ 0 0
    0/300
     
    ¸ÞÀϺ¸³»±â
    ±â»çÁ¦¸ñ : Àü¿µ±¸ ¾à»ç, Áö¹æ ÃʵîÇлý ÃÊû û¿Í´ë °ßÇÐ